Table 1.
Characteristics of Patients Who Had Growth Detected in Blood Cultures
| Characteristic | Total (N=1667) | SARS-CoV-2 Positive (n=395) | SARS-CoV-2 Negative (n=1272) |
|---|---|---|---|
| Gender identity | |||
| Female | 718 (43.1) | 154 (39.0) | 564 (44.3) |
| Male | 949 (56.9) | 241 (61.0) | 708 (55.7) |
| Other | 0 | 0 | 0 |
| Age group, y | |||
| Children (<18) | 139 (8.3) | 6 (1.5) | 133 (10.5) |
| Adult (18–64) | 760 (45.6) | 211 (53.4) | 549 (43.2) |
| Elderly (≥65) | 768 (46.1) | 178 (45.1) | 590 (46.4) |
| Ethnicity | |||
| Non-white | 677 (40.6) | 204 (30.1) | 473 (69.9) |
| White | 656 (39.4) | 110 (16.8) | 546 (83.2) |
| Unknown | 334 (20.0) | 81 (20.5) | 253 (19.9) |
| ICU admission | |||
| Admitted to ICU | 517 (31.0) | 192 (48.6) | 325 (25.6) |
| Not admitted to ICU | 1150 (69.0) | 203 (51.4) | 947 (74.4) |
| Infection status | |||
| Developed hospital-acquired BSI | 314 (18.8) | 89 (28.3) | 225 (72.7) |
| Developed community-acquired BSI | 557 (33.4) | 80 (14.4) | 477 (85.6) |
| Had contaminants in blood culture | 796 (47.8) | 226 (28.4) | 570 (71.6) |
| COVID-19 status | |||
| Had SARS-CoV-2 test, positive | 395 (23.7) | NA | NA |
| Had SARS-CoV-2 test, negative | 954 (57.2) | NA | NA |
| Had no SARS-CoV-2 test | 318 (19.1) | NA | NA |
| In-hospital mortality | |||
| Deceased | 449 (26.9) | 134 (33.9) | 315 (24.8) |
| Alive | 1218 (73.1) | 261 (66.1) | 957 (75.2) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: BSI, bloodstream infection; COVID-19, coronavirus disease 2019; ICU, intensive care unit; NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.